Metastatic castration-resistant prostate cancer: Academic insights and perspectives through bibliometric analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metastatic castration-resistant prostate cancer: Academic insights and perspectives through bibliometric analysis

Published:2020-04 Issue:15 Volume:99 Page:e19760
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

He Lugeng,Fang Hui,Chen Chao,Wu Yanqi,Wang Yuyong,Ge Hongwei,Wang Lili,Wan Yuehua,He Huadong

Funder

Natural Science Foundation of Zhejiang Province

Zhejiang Medical Science and Technology Project

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference125 articles.

1. Cancer Statistics, 2018;Siegel;Ca-a Cancer Journal for Clinicians,2018

2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

3. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013

4. EAU guidelines on prostate cancer;Heidenreich;Eur Urol,2008

5. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent;Mottet;Eur Urol,2017

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of interventions for metastatic castration resistant prostate cancer (mCRPC) patients progressing on androgen receptor-axis-targeted (ARAT) therapy: a systematic literature review;Current Medical Research and Opinion;2024-08-27

2. Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS—Meet-URO 26 Study;Clinical Genitourinary Cancer;2024-08

3. Development and Preclinical Evaluation of [²¹¹At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate Cancer;Journal of Nuclear Medicine;2024-02-29

4. Novel treatment strategies to overcome resistance in prostate cancer;Therapy Resistance in Prostate Cancer;2024

5. Photoactivation of pheophorbide-a utilizing 670 nm LEDs elicits cancer suppressive effects in androgen-independent prostate cancer cellular models;Journal of Pharmacy and Pharmacology;2023-10-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3